Literature DB >> 16199073

Expression of a recombinant anticoagulant C-type lectin-like protein ACFI in Pichia pastoris: heterodimerization of two subunits is required for its function.

Siyi Hu1, Weifang Li, Lan Chen, Jing Liu.   

Abstract

ACFI is an anticoagulant C-type lectin-like protein (CLP) isolated from Agkistrodon acutus venom. To investigate the function of ACFI and its subunits, the cDNAs of two subunits were transformed and expressed in Pichia pastoris separately or together by a novel strategy using two vectors with different selectable markers. The results showed that recombinant homodimers were secreted when the subunits were expressed alone, while heterodimers (rACFI) were secreted when two subunits were co-expressed. The secreted proteins were purified from culture supernatants in one step by metal-chelating affinity chromatography with the yields of 1-4 mg/L. PAGE and ELISA showed that rACFI competed the binding of native ACFI for human factor X and IX with affinities of 1.6 and 30 nM, respectively. In addition, rACFI prolonged the activated partial thromboplastin time (APTT) in a concentration dependent manner as same as native ACFI. However, recombinant alpha or beta homodimers completely lost these activities, indicating the heterodimerization of two subunits is required for its function. It also suggests that P. pastoris is a promising system for structure-function studies of snake CLPs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199073     DOI: 10.1016/j.toxicon.2005.07.013

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  2 in total

1.  Effect of metal ion substitutions in anticoagulation factor I from the venom of Agkistrodon acutus on the binding of activated coagulation factor X and on structural stability.

Authors:  Xiaolong Xu; Liyun Zhang; Dengke Shen; Hao Wu; Lili Peng; Jiehua Li
Journal:  J Biol Inorg Chem       Date:  2009-01-31       Impact factor: 3.358

2.  Balancing the Expression and Production of a Heterodimeric Protein: Recombinant Agkisacutacin as a Novel Antithrombotic Drug Candidate.

Authors:  Yugang Guo; Jing Wu; Hao Jia; Wei Chen; Changsheng Shao; Lei Zhao; Jiajia Ma; Rui Li; Yongjun Zhong; Fang Fang; Dong Wang; Jie Sun; Fang Qian; Xiangrong Dai; Guohui Zhang; Zhigang Tian; Benjamin Xiaoyi Li; Weihua Xiao
Journal:  Sci Rep       Date:  2015-07-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.